Exelixis Inc. Common Stock vs Flex Ltd — how do they compare? Exelixis Inc. Common Stock trades at $59.43 (market cap $14.48B), while Flex Ltd trades at $116.02 (market cap $44.09B). The key difference: Flex Ltd is far larger — about 3× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Flex Ltd for 3 Days on average.
| EXEL | FLEX | |
|---|---|---|
Market Cap | $14.48B | $44.09B |
Volume | 2,374,774 | 3,022,166 |
Sector | Health | Technology |
52-Week High | $59.13 | $162.07 |
52-Week Low | $34.54 | $54.51 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $13.81B | $47.18B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →